JAYE KRUBALLY: Open Payments
NPI 1093132482 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 30 payments from 8 companies in 2025. Trend: 2023 $927 · 2024 $455 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $167 |
| ABBVIE INC. | 13 | $148 |
| Alkermes, Inc. | 1 | $122 |
| ACADIA Pharmaceuticals Inc | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Abbott Laboratories | 1 | $21 |
| Cipher Pharmaceuticals US LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, LYBALVI, DAYBUE, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Natroba, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
